Literature DB >> 10220822

[Neuro-meningeal location of Richter syndrome].

G Agard1, M Hamidou, S Leautez, R Garand, J Y Grolleau.   

Abstract

INTRODUCTION: The authors report a case of neurologic manifestations revealing Richter's syndrome in chronic lymphocytic leukemia. EXEGESIS: Cranial nerve palsies were the initial manifestation of the disease. Computed tomography and magnetic resonance imaging were normal. Cerebrospinal fluid analysis with alkaline phosphatase-antialkaline phosphatase revealed the existence of a large-cell lymphoma.
CONCLUSIONS: Clinical aspects of this unusual localization of Richter's syndrome are reviewed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10220822     DOI: 10.1016/s0248-8663(99)83011-2

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  4 in total

1.  Richter transformation of chronic lymphocytic leukemia presenting as a dural-based non-hodgkin lymphoma mass.

Authors:  M Ghofrani; B Tantiwongkosi; A S Smith; D A Wasdahl
Journal:  AJNR Am J Neuroradiol       Date:  2007-02       Impact factor: 3.825

2.  Richter's syndrome of the central nervous system diagnosed concurrently with chronic lymphocytic leukaemia: A case report and literature review.

Authors:  Liye Xu; Jin Cheng Song; Xiu Hua Sun; Zi Fen Gao; Li Lv; Jie Zhu
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

3.  Richter's transformation as leptomeningeal infiltration in a chronic lymphocytic leukemia patient receiving venetoclax. Could blood-brain barrier be a disease "sanctuary" during venetoclax treatment?

Authors:  Maria Dimou; Aikaterini Bitsani; Maria Roumelioti; Aglaia Dimitrakopoulou; Theodore Iliakis; Vasileios Pardalis; Ioannis Grafakos; Sotiria Kalyva; Athanasios Markopoulos; Marie-Christine Kyrtsonis; Panayiotis Panayiotidis
Journal:  Clin Case Rep       Date:  2021-03-04

4.  Isolated Richter's transformation of the brain.

Authors:  Anto Bagic; Vitalie D Lupu; Craig M Kessler; Carlo Tornatore
Journal:  J Neurooncol       Date:  2007-02-14       Impact factor: 4.506

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.